On 2:00 p.m, July 31, Alex Zhavoronkov PhD will be speaking at the session named “Methodologies and Considerations for Trials Involving Al-Driven Technologies” (IMAGE)

InSilico Medicine

On 2:00 p.m, July 31, Alex Zhavoronkov PhD will be speaking at the session named “Methodologies and Considerations for Trials Involving Al-Driven Technologies”

Caption

The session moderated by Associate Professor Liu Nan, Director of Duke-NUS Al+ Medical Sciences Initiative (DAlSl) explores the critical aspects of conducting trials for artificial intelligence (Al) technologies.

Credit

Insilico Medicine

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.